Meet Our Team
Ms. Lillian Jean
Chief Executive Officer
Ms. Lillian Jean
Chief Executive Officer
Ms. Lillian Jean is a dynamic and strategic leader with over 31 years of experience in the merger and acquisition (M&A) industry and driving organizational success across diverse industries. As the Chief Executive Officer of Aspen Capital Management LLC, she has successfully led the company in executing complex transactions, driving value creation, and navigating intricate regulatory environments. Ms. Jean is known for her deep expertise in deal structuring, negotiation, and integration, as well as for building strong relationships with stakeholders across the financial and corporate sectors. Under her leadership, Aspen Capital Management LLC has achieved a reputation for delivering successful outcomes in markets. As the Chief Executive Officer of Aspen Capital Management, she is responsible for steering the company’s strategic direction, fostering innovation, and ensuring sustainable growth.
James Rosebush
Executive Chairman of the Board
James Rosebush
Executive Chairman of the Board
JAMES ROSEBUSH was a Deputy Assistant to President Reagan, the Chief of Staff to First Lady Nancy Reagan, and a Senior Advisor at the White House. JAMES ROSEBUSH is a widely recognized leader in building and managing CORPORATE and PHILANTHROPIC organizations and serving as the outsourced CEO and senior adviser for WEALTHY FAMILIES, and family offices. For over twenty years he has been CEO of an international consulting firm, Growth Strategy, Inc., a company focused on management strategies, finance and wealth management, marketing, leadership coaching and communications, throughout the world.
James Rosebush serves as the Executive Chairman of Aspen Capital Management LLC, bringing years of leadership and expertise in the merger and acquisition (M&A) industry. In this role, he plays a pivotal part in shaping the strategic direction of the company, leveraging his extensive experience in deal-making, corporate governance, and business transformation to drive growth and shareholder value. As Executive Chairman, James Rosebush is deeply involved in the company’s most critical initiatives, from identifying high-potential acquisition targets to overseeing complex transactions and ensuring successful post-merger integration. He works closely with the CEO and the board of directors to set strategic priorities, guide corporate policy, and ensure that all M&A activities are aligned with the company’s long-term vision. Under his leadership, Aspen Capital Management LLC has solidified its position as a leader in the M&A space, known for executing transformative deals that have expanded the company’s market presence, enhanced its competitive edge, and delivered consistent returns for investors. James Rosebush’s strategic acumen, combined with his ability to foster strong relationships with key stakeholders, has been instrumental in navigating the complexities of the global market and steering the company towards sustained success because He pioneered a holistic approach to organizational consulting which has resulted in measurable growth in earnings or assets under management for corporate clients. Growth Strategy clients have included major international companies and startups such as JPMorgan, Mercedes-Benz, Tudor Investments, Bankers Trust, Bessemer Trust, McDonald's, Sapient, Cannon, Coca-Cola, The Carlyle Group, Stargazer Fund, Global Bond Fund, Columbia Capital, Cisco Systems, Calibre, Northgate Capital, Medigo, Children's Hospital Los Angeles, Mitretek, and over 300 others.
What he enjoys doing is developing and growing a company and excels at developing people and teams and building a foundation to sustain growth. he is an expert in analyzing existing operations and implementing effective systems, strategies, and processes to improve organizational performance and profitability.
Azahar Haque
Chief Operating Officer
Azahar Haque
Chief Operating Officer
Mr. Azahar Haque serves as the Chief Operating Officer of Aspen Capital Management LLC, where he plays a crucial role in overseeing the company’s day-to-day operations and ensuring the seamless execution of its merger and acquisition (M&A) strategies. With over 26 years of experience in the Real Estate industry, Mr. Haque is recognized for his operational excellence, strategic insight, and ability to drive complex projects to successful completion.
As COO, Mr. Haque is responsible for translating Aspen Capital Management LLC strategic goals into operational success. This includes managing the integration of acquired companies, optimizing processes, and ensuring that the company’s operations are aligned with its long-term vision. He works closely with the CEO and Executive Chairman to implement the company’s M&A strategy, ensuring that each transaction is executed efficiently and delivers maximum value.
Mr. Haque leadership in operational management extends to all aspects of the company’s functions, including finance, human resources, technology, and corporate development. He spearheads initiatives to streamline operations, enhance productivity, and foster a culture of continuous improvement. Mr. Haque is also deeply involved in risk management, ensuring that all operational risks are identified and mitigated throughout the M&A process.
What she enjoys doing is developing and growing a company and excels at developing people and teams and building a foundation to sustain growth. She is an expert in analyzing existing operations and implementing effective systems, strategies, and processes to improve organizational performance and profitability.
John Akhnoukh
Chief Medical Officer
John Akhnoukh
Chief Medical Officer
Dr. John Akhnoukh, M.D. is the Chief Medical Officer of Aspen Capital Management LLC, where he leads clinical strategy and medical oversight for healthcare acquisitions. A native New Yorker, Dr. Akhnoukh brings extensive medical training and a deep understanding of patient care, health systems, and interventional medicine to his role. He is a graduate of CUNY City College's accelerated Biomedical Education program and earned his medical degree from SUNY Downstate College of Medicine. He completed residency in Anesthesiology and Pain Medicine at Mount Sinai West and advanced his expertise through fellowship training at the Weill Cornell Tri-Institutional Pain Program—rotating through New York-Presbyterian Hospital, Memorial Sloan Kettering, and Hospital for Special Surgery.
Dr. Akhnoukh plays a key role in evaluating and integrating clinical operations across Aspen’s healthcare acquisitions, ensuring high standards of care, compliance, and strategic alignment. He is known for his expertise in interventional pain management, using multimodal techniques such as spinal cord stimulation, joint injections, and regenerative therapies. Passionate about outcomes, he addresses both the physical and emotional aspects of care and is committed to advancing patient-centered models.
What Dr. Akhnoukh enjoys most is building systems that restore function and improve lives. He excels in translating medical needs into scalable strategies and is instrumental in guiding Aspen’s mission to deliver operational excellence and value-driven care. A collaborative leader with a deep commitment to innovation, Dr. Akhnoukh embodies the values of integrity, empathy, and clinical excellence.
Mr. Chorne has been widely recognized across the golf and sports industries, having been featured in television, radio, newspapers, and magazines for his groundbreaking inventions and industry expertise. A business owner, executive, and golf professional, he has designed and patented several revolutionary products in golf club design, grip manufacturing, and shaft technology. His work has been highlighted by AT&T Sports Science and Technology on ABC-TV, ESPN’s Hale Irwin’s Golfing America, The Robb Report, ALBA Magazine (Japan), Newsday, and other global publications.
Beyond his contributions to product innovation, Mr. Chorne has played a key role in club fitting for numerous Tour players and has provided expert analysis in golf-related legal cases. His analytical mindset and strategic thinking enable him to identify unique business advantages that set companies apart from their competition.
At Aspen Capital Management LLC, Mr. Chorne works closely with the executive leadership team, including the CEO and CFO, to shape the company’s business development strategies. He also partners with the M&A team to develop business models that assess potential opportunities and risks, ensuring all transactions align with the company’s long-term financial and strategic goals.
Syed Mahadi
Vice President - Financial Planning and Analysis
Syed Mahadi
Vice President - Financial Planning and Analysis
Mr. Syed Mahadi serves as the Vice President of Financial Planning and Analysis (FP&A) at Aspen Capital Management LLC, where he leads the strategic financial planning, budgeting, and analysis efforts that drive the company’s merger and acquisition (M&A) activities. With over 13 years of experience in finance, Mr. Mahadi is a seasoned expert in delivering insightful financial analyses, developing robust financial models, and providing strategic guidance that supports Aspen Capital Management LLC growth objectives.
In his role, Aspen Capital Management LLC is responsible for overseeing all aspects of financial planning and analysis, including forecasting, budgeting, and long-term financial strategy. He plays a critical role in evaluating potential M&A opportunities, conducting thorough financial due diligence, and assessing the financial impact of transactions. By providing clear, data-driven insights, Mr. Mahadi ensures that Aspen Capital Management LLC makes informed decisions that align with its strategic goals and deliver maximum value to stakeholders.
Mr. Mahadi collaborates closely with the executive team, including the CEO, CFO, and other senior leaders, to shape the company’s financial strategy. He also works directly with the M&A team to develop financial models that assess the potential risks and rewards of each deal, ensuring that all transactions are financially sound and strategically beneficial.